About: Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 November 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im Januar 2018 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована у 2018 (uk) artículu científicu espublizáu en payares de 2018 (ast) scientific article published on 11 November 2018 (en) 2018 թվականի նոյեմբերի 11-ին հրատարակված գիտական հոդված (hy)
publication date	wds:Q59811230-43C7C8FC-0D06-4FFB-A61A-069A6FDDB67C
publication date	2018-11-11 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59811230-AF6E42E2-D6DD-4A21-BE26-C79F10F970AA
language of work or name	English
cites work	wds:Q59811230-00B9300F-BCB4-4A75-8544-1269294817F8 wds:Q59811230-14DAE861-BADB-440E-BD92-8AA62AC99A1F wds:Q59811230-1552F03C-E201-4FF5-8660-C3A6C6C1B366 wds:Q59811230-1ED116ED-BA21-417E-9CF6-368D0B20B923 wds:Q59811230-25015544-0DCD-40C7-8E9D-5C7AC76685B6 wds:Q59811230-29B19942-5703-48DD-913A-8514DFEA3AA0 wds:Q59811230-56BFB21B-88D2-4763-A461-ECAD0F26CCC6 wds:Q59811230-6F301790-F811-4F54-88B6-C8E8A9AA51CB wds:Q59811230-8A3975DB-80D1-45FE-8E8A-99FE6C7BABDF wds:Q59811230-9392572C-B535-4CEA-9BBE-05F06CECE129 wds:Q59811230-ADB0D164-D0C4-4DDE-B081-8C99B46487C6 wds:Q59811230-B592B333-A6E7-4B18-9B6A-80464ED7318F wds:Q59811230-B9D7B3D8-9251-4748-8B05-D55AEA537713 wds:Q59811230-BC4E29EC-8AA1-4485-9AE7-769CA755595D wds:Q59811230-BCF20795-2548-4AE3-BB48-363133EA3C5D wds:Q59811230-C64E90D4-3BE7-4F07-94F6-EA1AFD14C70A wds:Q59811230-C7A148C0-5847-46EA-9FF4-5F440D500C7D wds:Q59811230-EB253C64-A74F-45E7-848A-0168229F0C2C wds:Q59811230-F4A06C91-3766-4236-A611-9F57F503D939 wds:Q59811230-FA6DE51A-4A7B-45C1-9F0C-1D6CC4A1591F
cites work	MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Homing of cancer cells to the bone OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine Is prostate-specific membrane antigen a multifunctional protein? 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions. German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer. Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis. Absolute organ activity estimated by five different methods of background correction. Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy. Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study Clinical translation of a PSMA inhibitor for 99mTc-based SPECT. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT. 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients
author name string	wds:Q59811230-1FB9DD48-8735-48F3-A895-6E3441A5531C wds:Q59811230-55C9F3A6-268E-4F61-8830-81402F323BFA wds:Q59811230-586795BF-D187-4F50-9839-46F8EEDEC33B wds:Q59811230-B75598D7-CE33-4AA5-8B3B-586851731936 wds:Q59811230-C7F1ADD5-6D04-4BB4-83F0-2A1A2D44C1CE
author name string	Francisco O García-Pérez Jenny Davanzo Nallely Jiménez-Mancilla Myrna Luna-Gutiérrez Irma Soldevilla-Gallardo
rdfs:label	Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer (en) Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer (nl)
skos:prefLabel	Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer (en) Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer (nl)
name	Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer (en) Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer (nl)
author	wds:Q59811230-1FF49039-33AB-4390-A325-4D7183F11962 wds:Q59811230-8517AF59-3439-4575-9F2E-E30332759D8E wds:Q59811230-97BA4D4B-099D-4EF7-BDBE-0BE0B8F1E627 wds:Q59811230-A10B76B7-2C54-468A-9C26-EE234B4EDC5A wds:Q59811230-D6A87D44-A67A-4176-8C87-93F3A539BADC
author	Erika Patricia Azorin-Vega Clara L Santos-Cuevas Blanca E Ocampo-García Guillermina Ferro-Flores Gerardo J Ramírez-Nava
title	wds:Q59811230-2F48CFA0-CCAF-4608-96FD-26E8740762E2
title	177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer (en)
page(s)	wds:Q59811230-5AC57814-8085-4459-8AEE-AAA20EA10DED
page(s)	5247153
instance of	wds:Q59811230-F2EC8327-8EFE-45A7-A6D9-B156989CF844
instance of	scholarly article
PubMed ID	wds:Q59811230-11E1B53F-FF14-473B-AA46-E168D14C28F8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30534027
PubMed ID	30534027
published in	wds:Q59811230-17E3BD51-C6C5-442D-B38A-4D04888EC096
published in	Contrast Media & Molecular Imaging
volume	wds:Q59811230-C815343D-A3EC-4F7C-9014-9B018DA966B2
volume	2018
DOI	wds:Q59811230-B8CDBC4A-E597-4391-B650-FD07CAC800E8
DOI	http://dx.doi.org/10.1155/2018/5247153
DOI	10.1155/2018/5247153
copyright license	wds:Q59811230-7D14EC4D-95B1-4B17-AEAF-5F1808DD7CAC
copyright status	wds:Q59811230-DBFC49D5-9478-4322-9672-D2C55B3B1D8C
copyright license	Creative Commons Attribution 4.0 International
copyright status	copyrighted
describes a project that uses	wds:Q59811230-144B9108-7799-4301-80A0-E92C062A05F4
describes a project that uses	ImageJ
PMCID	wds:Q59811230-50DEBD9A-21FC-4AC1-B0F2-F81DC4247F99

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software